Projecten
Evaluatie van SARS-coV2 varianten in cohorten van zwangere vrouwen en kinderen Universiteit Hasselt
Rapid European SARS-CoV-2 Emergency research Response (RECoVER). Universiteit Antwerpen
GynCoviRisk – Beoordeling van het risico van SARS-CoV-2 voor zwangerschap en als mogelijke oorzaak van aangeboren afwijkingen KU Leuven
In the GynCoviRisk project, we combine (A) the expertise in gynaecology and obstetrics of the candidate with (B) the leadership of the hosting lab in studying SARS-CoV-2 pathogenesis to investigate
(i) to what extent infection impacts maternal health during pregnancy,
(ii) whether vertical transmission occurs during embryogenesis and foetal development, and
(iii) if/how this interferes with ...
Evaluatie van SARS-coV2-varianten in cohorten zwangerschap en pediatrie (VERDI). Universiteit Antwerpen
Verbinden van Europese cohorten om de gemeenschappelijke en effectieve respons op SARS-CoV-2-pandemie te vergroten (ORCHESTRA). Universiteit Antwerpen
Verbinden van Europese cohorten om een gemeenschappelijke en effectieve respons op SARS-CoV-2-pandemie te vergroten (ORCHESTRA). Universiteit Antwerpen
De menselijke genetische en immunologische determinanten van de klinische manifestaties van SARS-CoV-2-infectie: op weg naar gepersonaliseerde geneeskunde KU Leuven
The consequences of SARS-CoV-2 exposure range from a lack of infection to lethal COVID-19. This immense inter-individual clinical variability is the key scientific and medical enigma in the field. While age and certain co-morbidities are known to influence disease outcome, these parameters do not explain all variation. In addition, there are other SARS-CoV-2 phenotypes of clinical importance: multisystem inflammatory syndrome in children and ...
CARE Corona Versnelde R&D in Europa KU Leuven
The Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) pandemic has emerged as the largest global health threat to humanity in this century. According to the World Health Organisation Situation Report of March 28th 2020, 571,659 patients were diagnosed with Coronavirus Disease 2019 (COVID-19) and 26,493 deaths were reported globally. The wide spectrum of clinical symptoms, disease severity in high risk individuals, transmission ...
Duurzame COVID-19-vaccinatie voor langdurige immuniteit en effectiviteit van vaccins KU Leuven
Despite the rapid development of various SARS-CoV-2 vaccines, the control of the pandemic is hampered by the constant emergence of SARS-CoV-2 variants escaping vaccine-induced immunity and the waning of immunity. SOLVE will tackle these challenges by deciphering the mechanisms of induction of long-lasting immunity and evaluating new vaccine platforms. To achieve this goal, an integrated plan has been developed including six pillars: 1) ...